Insulet (PODD) Misses Q4 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $148.75 +0.43%
Revenue Growth %: +17.9%
Financial Fact:
Operating loss: 2.42M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: +17.9%
Financial Fact:
Operating loss: 2.42M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q4 EPS of ($0.16), $0.11 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $103.6 million versus the consensus estimate of $100.61 million.
GUIDANCE:
Insulet sees FY2017 revenue of $420-440 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI-powered cyber threats light a fire under cybersecurity stocks
- Truist names top clean energy stocks to watch ahead of Q3 earnings season
- Booz Allen Hamilton falls despite earnings beat
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
